By Matt Grossman
Abbott Laboratories Wednesday raised its full-year adjusted-earnings guidance, after revenue from Covid-19 testing helped lift its diagnostics business sales 48% in the third quarter.
The Abbott Park, Ill.-based medical-products company forecast adjusted earnings per share of $5.00 to $5.10 for the year. In July, Abbott was guiding for per-share adjusted earnings of $4.30 a share to $4.50 a share.
Analysts had expected full-year adjusted earnings of $4.46 a share, according to FactSet.
Write to Matt Grossman at email@example.com
(END) Dow Jones Newswires